127 related articles for article (PubMed ID: 15184866)
21. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells.
Veit C; Genze F; Menke A; Hoeffert S; Gress TM; Gierschik P; Giehl K
Cancer Res; 2004 Aug; 64(15):5291-300. PubMed ID: 15289335
[TBL] [Abstract][Full Text] [Related]
22. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
23. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
24. Stress induces activation of stress-activated kinases in the mouse brain.
Liu YF; Bertram K; Perides G; McEwen BS; Wang D
J Neurochem; 2004 May; 89(4):1034-43. PubMed ID: 15140201
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of Jun N-terminal kinase and p38MAP kinase by Galpha12.
Dermott JM; Ha JH; Lee CH; Dhanasekaran N
Oncogene; 2004 Jan; 23(1):226-32. PubMed ID: 14712227
[TBL] [Abstract][Full Text] [Related]
26. MKK4 acts as a potential tumor suppressor in ovarian cancer.
Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
Tumour Biol; 2011 Aug; 32(4):661-70. PubMed ID: 21487811
[TBL] [Abstract][Full Text] [Related]
27. Requirement of MKK4 and MKK7 for CdCl2- or HgCl2-induced activation of c-Jun NH2-terminal kinase in mouse embryonic stem cells.
Matsuoka M; Igisu H; Nakagawa K; Katada T; Nishina H
Toxicol Lett; 2004 Sep; 152(2):175-81. PubMed ID: 15302099
[TBL] [Abstract][Full Text] [Related]
28. The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway.
Atfi A; Prunier C; Mazars A; Défachelles AS; Cayre Y; Gespach C; Bourgeade MF
Oncogene; 1999 Jul; 18(26):3878-85. PubMed ID: 10445851
[TBL] [Abstract][Full Text] [Related]
29. Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression.
Ahn YH; Yang Y; Gibbons DL; Creighton CJ; Yang F; Wistuba II; Lin W; Thilaganathan N; Alvarez CA; Roybal J; Goldsmith EJ; Tournier C; Kurie JM
Mol Cell Biol; 2011 Nov; 31(21):4270-85. PubMed ID: 21896780
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
31. SEK1/MKK4-mediated SAPK/JNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosis.
Watanabe T; Nakagawa K; Ohata S; Kitagawa D; Nishitai G; Seo J; Tanemura S; Shimizu N; Kishimoto H; Wada T; Aoki J; Arai H; Iwatsubo T; Mochita M; Watanabe T; Satake M; Ito Y; Matsuyama T; Mak TW; Penninger JM; Nishina H; Katada T
Dev Biol; 2002 Oct; 250(2):332-47. PubMed ID: 12376107
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells.
Mingo-Sion AM; Marietta PM; Koller E; Wolf DM; Van Den Berg CL
Oncogene; 2004 Jan; 23(2):596-604. PubMed ID: 14724588
[TBL] [Abstract][Full Text] [Related]
33. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
Lotan T; Hickson J; Souris J; Huo D; Taylor J; Li T; Otto K; Yamada SD; Macleod K; Rinker-Schaeffer CW
Cancer Res; 2008 Apr; 68(7):2166-75. PubMed ID: 18381422
[TBL] [Abstract][Full Text] [Related]
34. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines.
Tournier C; Dong C; Turner TK; Jones SN; Flavell RA; Davis RJ
Genes Dev; 2001 Jun; 15(11):1419-26. PubMed ID: 11390361
[TBL] [Abstract][Full Text] [Related]
35. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.
Vander Griend DJ; Kocherginsky M; Hickson JA; Stadler WM; Lin A; Rinker-Schaeffer CW
Cancer Res; 2005 Dec; 65(23):10984-91. PubMed ID: 16322247
[TBL] [Abstract][Full Text] [Related]
36. MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course.
Xin W; Yun KJ; Ricci F; Zahurak M; Qiu W; Su GH; Yeo CJ; Hruban RH; Kern SE; Iacobuzio-Donahue CA
Clin Cancer Res; 2004 Dec; 10(24):8516-20. PubMed ID: 15623633
[TBL] [Abstract][Full Text] [Related]
37. New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells.
Taylor JL; Szmulewitz RZ; Lotan T; Hickson J; Griend DV; Yamada SD; Macleod K; Rinker-Schaeffer CW
Cancer Lett; 2008 Dec; 272(1):12-22. PubMed ID: 18572308
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia.
Lotan TL; Lyon M; Huo D; Taxy JB; Brendler C; Foster BA; Stadler W; Rinker-Schaeffer CW
J Pathol; 2007 Aug; 212(4):386-94. PubMed ID: 17577251
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the metastasis suppressor gene MKK4 in ovarian cancer.
Spillman MA; Lacy J; Murphy SK; Whitaker RS; Grace L; Teaberry V; Marks JR; Berchuck A
Gynecol Oncol; 2007 May; 105(2):312-20. PubMed ID: 17276500
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of anchorage-independent growth of human pancreatic carcinoma MIA PaCa-2 cells by signaling from protein kinase C to mitogen-activated protein kinase.
Ishino K; Fukazawa H; Shikano M; Ohba M; Kuroki T; Uehara Y
Mol Carcinog; 2002 Aug; 34(4):180-6. PubMed ID: 12203369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]